Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Immunicum begins ilixadencel combination therapy in ILIAD trial

Ilixadencel is a cell therapy candidate designed as an off-the-shelf cancer immune primer. Credit: Weining Zhong.



  • Immunicum begins ilixadencel combination therapy in ILIAD trial

Go Top